Profound Medical (PROF) Expected to Announce Earnings on Thursday

Profound Medical (NASDAQ:PROF - Get Free Report) is expected to issue its quarterly earnings data after the market closes on Thursday, March 6th. Analysts expect the company to announce earnings of ($0.31) per share and revenue of $5.92 million for the quarter.

Profound Medical Price Performance

Profound Medical stock traded down $0.22 during trading hours on Friday, hitting $6.93. 52,791 shares of the company traded hands, compared to its average volume of 80,202. Profound Medical has a 1-year low of $5.63 and a 1-year high of $11.42. The company has a quick ratio of 5.16, a current ratio of 6.12 and a debt-to-equity ratio of 0.11. The firm's 50-day simple moving average is $7.01 and its two-hundred day simple moving average is $7.66. The firm has a market cap of $208.18 million, a P/E ratio of -5.17 and a beta of 0.88.

Analyst Upgrades and Downgrades

Separately, Raymond James raised shares of Profound Medical to a "strong-buy" rating in a report on Saturday, November 9th.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.